Market closed

Curis/CRIS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Curis

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Ticker

CRIS
Trading on

Industry

Biotechnology

Employees

49

Curis Metrics

BasicAdvanced
$30M
Market cap
-
P/E ratio
-$8.23
EPS
3.35
Beta
-
Dividend rate
$30M
3.35
$17.49
$3.80
44K
1.783
1.596
-4,573.631
-6,039.914
-62.17%
-45.97%
-372.68%
2.888
-43.22
-3.1
-0.687
-0.44%
-18.00%
-0.26%
-3.27%

What the Analysts think about Curis

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Curis stock.

Curis Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Curis Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy CRIS

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Curis stock?

Curis (CRIS) has a market cap of $30M as of October 08, 2024.

What is the P/E ratio for Curis stock?

The price to earnings (P/E) ratio for Curis (CRIS) stock is 0 as of October 08, 2024.

Does Curis stock pay dividends?

No, Curis (CRIS) stock does not pay dividends to its shareholders as of October 08, 2024.

When is the next Curis dividend payment date?

Curis (CRIS) stock does not pay dividends to its shareholders.

What is the beta indicator for Curis?

Curis (CRIS) has a beta rating of 3.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.